COVID-19: Navigating practice and “at-risk” patient pathways

The fields of ophthalmology and optometry have been the financially hardest hit healthcare sectors by the COVID-19 pandemic, and the implications will be felt well after the crisis has passed. In the midst of this, intermediate dry age-related macular degeneration (AMD) patients have been largely overlooked and are at greater risk of undetected conversion for an extended period of time while practices prioritize which patients to reschedule or book for telehealth visits.

Learn how you can protect these at-risk patients through remote monitoring with the ForeseeHome^® AMD Monitoring Program. Richard Garfinkel, MD from the Retina Group of Washington discusses the importance of detecting wet AMD early, shares his conversion catch cases, and provides practical telehealth implementation insights that can be used now and in the future.